Year : 2010  |  Volume : 52  |  Issue : 7  |  Page : 189--199

Substance use and addiction research in India

Pratima Murthy, N Manjunatha, BN Subodh, Prabhat Kumar Chand, Vivek Benegal 
 Department of Psychiatry, De-Addiction Centre, National Institute of Mental Health and Neuro Sciences, Bangalore - 560 029, India

Correspondence Address:
Pratima Murthy
Department of Psychiatry, De-Addiction Centre, National Institute of Mental Health and Neuro Sciences, Bangalore - 560 029


Substance use patterns are notorious for their ability to change over time. Both licit and illicit substance use cause serious public health problems and evidence for the same is now available in our country. National level prevalence has been calculated for many substances of abuse, but regional variations are quite evident. Rapid assessment surveys have facilitated the understanding of changing patterns of use. Substance use among women and children are increasing causes of concern. Preliminary neurobiological research has focused on identifying individuals at high risk for alcohol dependence. Clinical research in the area has focused primarily on alcohol and substance related comorbidity. There is disappointingly little research on pharmacological and psychosocial interventions. Course and outcome studies emphasize the need for better follow-up in this group. While lack of a comprehensive policy has been repeatedly highlighted and various suggestions made to address the range of problems caused by substance use, much remains to be done on the ground to prevent and address these problems. It is anticipated that substance related research publications in the Indian Journal of Psychiatry will increase following the journal having acquired an «SQ»indexed«SQ» status.

How to cite this article:
Murthy P, Manjunatha N, Subodh B N, Chand PK, Benegal V. Substance use and addiction research in India.Indian J Psychiatry 2010;52:189-199

How to cite this URL:
Murthy P, Manjunatha N, Subodh B N, Chand PK, Benegal V. Substance use and addiction research in India. Indian J Psychiatry [serial online] 2010 [cited 2020 Apr 5 ];52:189-199
Available from:

Full Text


Substance use has been a topic of interest to many professionals in the area of health, particularly mental health. An area with enormous implications for public health, it has generated a substantial amount of research. In this paper we examine research in India in substance use and related disorders. Substance use includes the use of licit substances such as alcohol, tobacco, diversion of prescription drugs, as well as illicit substances.


For this review, we have carried out a systematic web-based review of the Indian Journal of Psychiatry (IJP). The IJP search included search of both the current and archives section and an issue-to-issue search of articles with any title pertaining to substance use. This has included original articles, reviews, case series and reports with significant implications. Letters to editor and abstracts of annual conference presentations have not been included.

Publications in other journals were accessed through a Medlar search (1992-2009) and a Pubmed search (1950-2009). Other publications related to substance use available on the websites of international and national agencies have also been reviewed. In this review, we focus mainly on publications in the IJP and have selectively reviewed the literature from other sources.

For the sake of convenience, we discuss the publications under the following areas: Epidemiology, clinical issues (diagnosis, psychopathology, comorbidity), biological studies (genetics, imaging, electrophysiology, and vulnerability), interventions and outcomes as well as community interventions and policies. There is a vast amount of literature on tobacco use and consequences in international and national journals, but this is outside the scope of this review. Tobacco is mentioned in this review of substance use to highlight that it should be remembered as the primary licit substance of abuse in our country.


The number of articles (area wise) available from IJP, other Indian journals and international journals are indicated in [Figure 1] and [Figure 2]. A majority of the publications in international journals relate to tobacco, substance use co-morbidity and miscellaneous areas like animal studies.{Figure 1}{Figure 2}


Much of the earlier epidemiological research has been regional and it has been very difficult to draw inferences of national prevalence from these studies.

Regional studies

Studies between 1968 until 2000 have been primarily on alcohol use [Table 1]. They have varied in terms of populations surveyed (ranged from 115 to 16,725), sampling procedures (convenient, purposive and representative), focus of enquiry (alcohol use, habitual excessive use, alcohol abuse, alcoholism, chronic alcoholism, alcohol and drug abuse and alcohol dependence), location (urban, rural or both, Slums), in the screening instruments used (survey questionnaires and schedules, semi-structured interviews, quantity frequency index, Michigan Alcohol Screening Test (MAST) etc). Alcohol 'use/abuse' prevalence in different regions has thus varied from 167/1000 to 370/1000; 'alcohol addiction' or 'alcoholism' or 'chronic alcoholism' from 2.36/1000 to 34.5/1000; alcohol and drug use/abuse from 21.4 to 28.8/1000. A meta-analysis by Reddy and Chandrashekhar [26] (1998) revealed an overall substance use prevalence of 6.9/1000 for India with urban and rural rates of 5.8 and 7.3/1000 population. The rates among men and women were 11.9 and 1.7% respectively.{Table 1}

Regional studies between 2001 and 2007 continue to reflect this variability. Currently, the interest is to look at hazardous alcohol use. A study in southern rural India [27] showed that 14.2% of the population surveyed had hazardous alcohol use on the AUDIT. A similar study in the tertiary hospital [28] showed that 17.6% admitted patients had hazardous alcohol use.

The only incidence study on alcohol use from Delhi [17] found that annual incidence of nondependent alcohol use and dependent alcohol use among men was 3 and 2 per 1000 persons in a total cohort of 2,937 households.

National Studies

The National Household Survey of Drug Use in the country [29] is the first systematic effort to document the nation-wide prevalence of drug use [Table 2]. Alcohol (21.4%) was the primary substance used (apart from tobacco) followed by cannabis (3.0%) and opioids (0.7%). Seventeen to 26% of alcohol users qualified for ICD 10 diagnosis of dependence, translating to an average prevalence of about 4%. There was a marked variation in alcohol use prevalence in different states of India (current use ranged from a low of 7% in the western state of Gujarat (officially under Prohibition) to 75% in the North-eastern state of Arunachal Pradesh. Tobacco use prevalence was high at 55.8% among males, with maximum use in the age group 41-50 years.{Table 2}

The National Family Health Survey (NFHS) [30] provides some insights into tobacco and alcohol use. The changing trends between NFHS 2 and NFHS 3 reflect an increase in alcohol use among males since the NFHS 2, and an increase in tobacco use among women.

The Drug Abuse Monitoring System, [29] which evaluated the primary substance of abuse in inpatient treatment centres found that the major substances were alcohol (43.9%), opioids (26%) and cannabis (11.6%).

Patterns of substance use

Rapid situation assessments (RSA) are useful to study patterns of substance use. An RSA by the UNODC in 2002 [31] of 4648 drug users showed that cannabis (40%), alcohol (33%) and opioids (15%) were the major substances used. A Rapid Situation and Response Assessment (RSRA) among 5800 male drug users [32] revealed that 76% of the opioid users currently injected buprenorphine, 76% injected heroin, 70% chasing and 64% using propoxyphene. Most drug users concomitantly used alcohol (80%). According to the World Drug Report, [33] of 81,802 treatment seekers in India in 2004-2005, 61.3% reported use of opioids, 15.5% cannabis, 4.1% sedatives, 1.5% cocaine, 0.2% amphetamines and 0.9% solvents.

Special populations

In the last decade, there has been a shift in viewing substance use and abuse as an exclusive adult male phenomenon to focusing on the problem in other populations. In the GENACIS study [34] covering a population of 2981 respondents [1517 males; 1464 females], across five districts of Karnataka, 5.9% of all female respondents (N =87) reported drinking alcohol at least once in the last 12 months, compared to 32.7% among male respondents (N = 496). Special concerns with women's drinking include the fetal alcohol spectrum effects described with alcohol use during pregnancy. [35]

Abuse of other substances among women has largely been studied through Rapid Assessment Surveys. A survey of 1865 women drug users by 110 NGOs across the country [36] revealed that 25% currently were heroin users, 18% used dextropropoxyphene, 11% opioid containing cough syrups and 7% buprenorphine. Eighty seven per cent concomitantly used alcohol and 83% used tobacco. Twenty five per cent of respondents had lifetime history of injecting drug use and 24% had been injecting in the previous month. There are serious sexually transmitted disease risks, including HIV that women partners and drug users face. [36],[37]

Substance use in medical fraternity

As early as 1977, a drug abuse survey in Lucknow among medical students revealed that 25.1% abused a drug at least once in a month. Commonly abused drugs included minor tranquilizers, alcohol, amphetamines, bhang and non barbiturate sedatives. In a study of internees on the basis of a youth survey developed by the WHO in 1982, [38] 22.7% of males 'indulged in alcohol abuse' at least once in a month, 9.3% abused cannabis, followed by tranquilizers. Common reasons cited were social reasons, enjoyment, curiosity and relief from psychological stress. Most reported that it was easy to obtain drugs like marijuana and amphetamines. Substance use among medical professionals has become the subject of recent editorials. [39],[40]

Substance use among children

The Global Youth Tobacco Survey [41] in 2006 showed that 3.8% of students smoke and 11.9% currently used smokeless tobacco. Tobacco as a gateway to other drugs of abuse has been the topic of a symposium. [42]

A study of 300 street child laborers in slums of Surat in 1993 [43] showed that 135 (45%) used substances. The substances used were smoking tobacco, followed by chewable tobacco, snuff, cannabis and opioids. Injecting drug use [44] is also becoming apparent among street children as are inhalants. [45]

A study in the Andamans [46] shows that onset of regular use of alcohol in late childhood and early adolescence is associated with the highest rates of consumption in adult life, compared to later onset of drinking.

Studies in other populations

A majority of 250 rickshaw pullers interviewed in New Delhi [47] in 1986 reported using tobacco (79.2%), alcohol (54.4%), cannabis (8.0%) and opioids (0.8%). The substances reportedly helped them to be awake at night while working. In a study of prevalence of psychiatric illness in an industrial population [48] in 2007, harmful use/dependence on substances (42.83%) was the most common psychiatric condition. A study among industrial workers from Goa on hazardous alcohol use using the AUDIT and GHQ 12 estimated a prevalence of 211/1000 with hazardous drinking. [19]

Hospital-based studies

These studies have basically described profiles of substance use among patients and include patterns of alcohol use, [49],[50],[51],[52],[53] opioid use, [54],[55],[56] pediatric substance use, [57] female substance use, [58] children of alcoholics [59] and geriatric substance use. [60]

Alcohol misuse has been implicated in 20% of brain injuries [61] and 60% of all injuries in the emergency room setting. [62] In a retrospective study of emergency treatment seeking in Sikkim between 2000 and 2005, [63] substance use emergencies constituted 1.16% of total psychiatric emergencies. Alcohol withdrawal was the commonest cause for reporting to the emergency (57.4%).

Effects of substance use disorders

Mortality and morbidity due to alcohol and tobacco have been extensively reviewed elsewhere [35],[64],[65],[66] and are beyond the scope of this review. The effects of cannabis have also been reviewed. [67] Mortality with injecting drug use is a serious concern with increase in crude mortality rates to 4.25 among injecting drug users compared to the general population. [68] Increased susceptibility to HIV/AIDS and other sexually transmitted diseases has been reported with alcohol [69] as well as injecting drug use. [70]

Clinical issues

Harmful alcohol use patterns among admitted patients in general hospital has highlighted the importance of routine screening and intervention in health care settings. [71]

Peer influence is a significant factor for heroin initiation. [72] Precipitants of relapse (dysfunction, stress and life events) differ among alcohol and opioid dependents. [73] Chronologies in the development of dependence have been evaluated in alcohol dependence. [74],[75]

Craving a common determinant of relapse has been shown to reduce with increase in length of period of abstinence. [76]

Alcohol dependence constitutes a significant group among the psychiatric population in the Armed Forces. [77] A study of personality factors [78] among 100 alcohol dependent persons showed significantly high neuroticism, extroversion, anxiety, depression, psychopathic deviation, stressful life events and significantly low self-esteem as compared with normal control subjects. Alcohol dependence causes impairment in set shifting, visual scanning and response inhibition abilities and relative abstinence has been found to improve this deficit. [79],[80] Alcohol use has had a significant association with head injury and cognitive deficits. [81],[82] Persistent drinking is associated with persisting memory deficits in head injured alcohol dependent patients. [82] Mild intellectual impairment has been demonstrated in patients with bhang and ganja dependence. [83],[84],[85],[86]

Kumar and Dhawan [87] found that health related reasons like death/physical complications due to drug use in peers and patients themselves, knowledge of HIV and difficulties in accessing veins were the main reason for reverse transition (shift from parenteral to inhalation route).

Evaluation and assessment

Diagnostic issues have focused on cross-system agreement [88] between ICD-10 and DSM IV, variability in diagnostic criteria across MAST, RDC, DSM and ICD [89] and suitability of MAST as a tool for detecting alcoholism. [90] The CIWA-A was found useful in monitoring alcohol withdrawal syndrome. [91]

The utility of liver functions for diagnosis of alcoholism and monitoring recovery has been demonstrated in clinical settings. [92],[93],[94] A range of hepatic dysfunction has been demonstrated through liver biopsies. [95]

A few studies have focused on scale development for motivation [96],[97] and addiction related dysfunction [98] (Brief Addiction Rating Scale). An evaluation of two psychomotor tests comparing smokers and non-smokers found no differences across the two groups. [99]

Typology research has included validation of Babor's [100] cluster A and B typologies, age of onset typology, [101] and a review on typology of alcoholism. [102]

Craving plays an important role in persistence of substance use and relapse. Frequency of craving has been shown to decrease with increase in length of abstinence among heroin dependent patients. Socio-cultural factors did not influence the subjective experience of craving. [76]

In a study of heroin dependent patients, their self-report moderately agreed with urinalysis using thin layer chromatography (TLC), gas liquid chromatography (GLC) and high performance liquid chromatography (HPLC). [103] The authors, however, recommend that all drug dependence treatment centers have facilities for drug testing in order to validate self-report.

Comorbidity/dual diagnosis

Cannabis related psychopathology has been a favorite topic of enquiry in both retrospective [104],[105] and prospective studies [106] and vulnerability to affective psychosis has been highlighted. The controversial status of a specific cannabis withdrawal syndrome and cannabis psychosis has been reviewed. [67]

High life time prevalence of co-morbidity (60%) has been demonstrated among both opioid and alcohol dependent patients. [107] In alcohol dependence, high rates of depression and cluster B personality disorders [54],[108] and phobia [109] have been demonstrated, but the need to revaluate for depressive symptoms after detoxification has been highlighted. [110] It is necessary to evaluate for ADHD, particularly in early onset alcohol dependent patients. [111] Seizures are overrepresented in subjects with alcohol and merit detailed evaluation. [112] Delirium and convulsions can also complicate opioid withdrawal states. [113],[114] Skin disease, [115] and sexual dysfunction [116] have also been the foci of enquiry. Phenomenological similarities between alcoholic hallucinosis and paranoid schizophrenia have been discussed. [117] Opioid users with psychopathology [118] have diverse types of psychopathology as do users of other drugs. [119]

In a study of 22 dual diagnosed schizophrenia patients, substance use disorder preceded the onset of schizophrenic illness in the majority. [120] While one study found high rates of comorbid substance use (54%) in patients with schizophrenia with comorbid substance users showing more positive symptoms [121] which remitted more rapidly in the former group, [122] other studies suggest that substance use comorbidity in schizophrenia is low, and is an important contributor to better outcome in schizophrenia in developing countries like India. [123],[124]

The diagnosis and management of dual diagnosis has been reviewed in detail. [125]

Social factors

Co-dependency has been described in spouses of alcoholics and found to correlate with the Addiction Severity scores of their husbands. [126] Coping behavior described among wives of alcoholics include avoidance, indulgence and fearful withdrawal. [127] These authors did not find any differences in personality between wives of alcoholics compared to controls. [128] Delusional jealousy and fighting behavior of substance abusers/dependents are important determinants of suicidal attempts among their spouses. [129] Parents of narcotic dependent patients, particularly mothers also show significant distress. [130]

 Biology of Addiction

An understanding of the cellular and molecular mechanisms of drug dependence has led to a reformulation of the etiology of this complex disorder. [131] An understanding of specific neurotransmitter systems has led to the development of specific pharmacotherapies for these disorders.

Cellular and molecular mechanisms

Altered alcohol metabolism due to polymorphisms in the alcohol metabolizing enzymes may influence clinical and behavioral toxicity due to alcohol. Erythrocyte aldehyde dehydrogenase was demonstrated to be suitable as a peripheral trait marker for alcohol dependence. [132] Single nucleotide polymorphism of the ALDH 2 gene has been studied in six Indian populations and provides the baseline for future studies in alcoholism. [133] An evaluation of ADH 1B and ALDH 2 gene polymorphism in alcohol dependence showed a high frequency of the ALDH2*2/*2 genotype among alcohol-dependent subjects. [134] DRD2 polymorphisms have been studied in patients with alcohol dependence, but a study in an Indian population failed to show a positive association. Genetic polymorphisms of the opioid receptor ΅1 has been associated with alcohol and heroin addiction in a population from Eastern India. [135]

Neuro-imaging and electrophysiological studies

Certain individuals may develop early and severe problems due to alcohol misuse and be poorly responsive to treatment. Such vulnerability has been related to individual differences in brain functioning [Figure 3]. Individuals with a high family history of alcoholism (specifically of the early-onset type, developing before 25 years of age) display a cluster of disinhibited behavioral traits, usually evident in childhood and persisting into adulthood. [136]

Early onset drinking may be influenced by delayed brain maturation. Alcohol-naοve male offspring of alcohol- dependent fathers have smaller (or slowly maturing) brain volumes compared to controls in brain areas responsible for attention, motivation, judgment and learning. [137],[138] The lag is hypothesized to work through a critical function of brain maturation-perhaps delayed myelination (insulation of brain pathways).{Figure 3}

Functionally, this is thought to create a state of central nervous system hyperexcitability or disinhibition. [139] Individuals at risk have also been shown to have specific electro-physiological characteristics such as reduced amplitude of the P300 component of the event related potential. [140],[141] Auditory P300 abnormalities have also been demonstrated among opiate dependent men and their male siblings. [142]

Such brain disinhibition is manifest by a spectrum of behavioral abnormalities such as inattention (low boredom thresholds), hyperactivity, impulsivity, oppositional behaviors and conduct problems, which are apparent from childhood and persist into adulthood. These brain processes not only promote impulsive risk-taking behaviors like early experimentation with alcohol and other substances but also appear to increase the reinforcement from alcohol while reducing the subjective appreciation of the level of intoxication, thus making it more likely that these individuals are likely not only to start experimenting with alcohol use at an early age but are more likely to have repeated episodes of bingeing. [143]

 Interventions, Course and Outcome

Although there are a few review articles on pharmacological treatment of alcoholism, [144],[145] there is a dearth of randomized studies on relapse prevention treatment in our setting.

Treatment of complications of substance use has been confined to case reports. A case report of thiamine resistant Wernicke Korsakoff Syndrome [146] successfully treated with a combination of magnesium sulphate and thiamine. Another case of subclinical psychological deterioration [147] (alcoholic dementia) improved with thiamine and vitamin B supplementation.

Pharmacological intervention

A randomized double blind study compared the effectiveness of detoxification with either lorazepam or chlordiazepoxide among hundred alcohol dependent inpatients with simple withdrawal. Lorazepam was found to be as effective as the more traditional drug chlordiazepoxide in attenuating alcohol withdrawal symptoms as assessed using the revised Clinical Institute Withdrawal Assessment for Alcohol scale. [148] This has implications for treatment in peripheral settings where liver function tests may not be available. However, benzodiazepines must be used carefully and monitored as dependence is very common. [149]

In a study closer to the real-world situation from Mumbai, 100 patients with alcohol dependence with stable families were randomized to receive disulfiram or topiramate. At the end of nine months, though patients on topiramate had less craving, a greater proportion of patients on disulfiram were abstinent (90% vs. 56%). Patients in the disulfiram group also had a longer time to their first drink and relapse. [150] Similar studies by the same authors and with similar methodology had earlier found that disulfiram was superior to acamprosate and Naltrexone. Though the study lacked blinding, it had an impressively low (8%) dropout rate. [151],[152] A chart based review has shown there was no significant difference with regard to abstinence among the patients prescribed acamprosate, naltrexone or no drugs. Although patients on acamprosate had significantly better functioning, lack of randomization and variations in base line selection parameters may have influenced these findings. [153] Short term use of disulfiram among alcohol dependence patients with smoking was not associated with decrease pulmonary function test (FEV 1 ) and airway reactivity. [154]

Usefulness of clonidine for opioid detoxification has been described by various authors. These studies date back to 1980 when there was no alternative treatment for opioid dependence and clonidine emerged as the treatment of choice for detoxification in view of its anti adrenergic activity. [155],[156],[157] Sublingual buprenorphine for detoxification among these patients was reported as early as 1992. At that time the dose used was much lower, i.e. 0.6 -1.2 mg/ day which is in contrast to the current recommended dose of 6-16 mg/day. Comparison of buprenorphine (0.6-1.2 mg/ day) and clonidine (0.3-0.9 mg/day) for detoxification found no difference among treatment non completers. Maximum drop out occurred on the fifth day when withdrawal symptoms were very high. [158] A 24- week outcome study of buprenorphine maintenance in opiate users showed high retention rates of 81.5%, reduction in Addiction Severity Index scores and injecting drug use. Use of slow release oral morphine for opioid maintenance has also been reported. [159] Effectiveness of baclofen in reducing withdrawal symptoms among three patients with solvent dependence is reported. [160]


Psychoeducational groups have been found to facilitate recovery in alcohol and drug dependence. [161] Family intervention therapy in addition to pharmacotherapy was shown to reduce the severity of alcohol intake and improve the motivation to stop alcohol in a case-control design study. [162] Several community based models of care have been developed with encouraging results. [163]

Course and outcome

An evaluation after five years, of 800 patients with alcohol dependence treated at a de-addiction center, found that 63% had not utilized treatment services beyond one month emphasizing the need to retain patients in follow-up. [164]

In a follow-up study on patients with alcohol dependence, higher income and longer duration of in-patient treatment were found to positively correlate with improved outcome at three month follow up. Outcome data was available for 52% patients; 81% of those maintained abstinence. [165] Maximum attrition was between three to six months. In a similar study among in-patients, 46% were abstinent. The drop out rate was 10% at the end of one year. [101] Studies done in the community setting have shown the effectiveness of continued care in predicting better outcome in alcohol dependence. In one study the patient group from a low socio-economic status who received weekly follow up or home visit at a clinic located within the slum showed improvement at the end of month 3, 6 and 9, and one year, in comparison with a control group that received no active follow-up intervention. [166] In a one-year prospective study of outcome following de-addiction treatment, poor outcome was associated with higher psychosocial problems, family history of alcoholism and more follow-up with mental health services. [167]

 Community Interventions and Policies

The camp approach for treatment of alcohol dependence was popularized by the TTK hospital camp approach at Manjakkudi in Tamil Nadu. [168] Treatment of alcohol and drug abuse in a camp setting as a model of drug de-addiction in the community through a 10 day camp treatment was found to have good retention rates and favorable outcome at six months.

Community perceptions of substance related problems are useful to understand for policy development. In a 1981 study in urban and rural Punjab of 1031 respondents, 45% felt people could not drink without producing bad effects on their health, 26.2% felt they could have one or two drinks per month without affecting their health. About one third felt it was alright to have one or two drinks on an occasion. 16.9% felt it was normal to drink 'none at all'. Alcoholics were identified by behavior such as being dead drunk, drinking too much, having arguments and fights and creating public nuisance. Current users gave the most permissive responses and non-users the most restrictive responses regarding the norms for drinking. [169] The influence of cultural norms [170] has led the tendency to view drugs as 'good' and 'bad'.

Simulations done in India have demonstrated that implementing a nationwide legal drinking age of 21 years in India, can achieve about 50-60 % of the alcohol consumption reducing effects compared to prohibition. [171] However, recently there are attempts to increase the permissible legal alcohol limit. This kind of contrarian approach does not make for coherent policy.

It has been argued that the 1970s saw an overzealous implementation of a simplistic model of supply and demand. [171] A presidential address [172] in 1991 emphasized the need for a multipronged approach to addressing alcohol-related problems. Existing programs have been identified as being patchy, poorly co-ordinated and poorly funded. Primary, secondary and tertiary approaches were discussed. The address highlighted the need for supply and demand side measures to address this significant public health problem. It highlighted the political and financial power of the alcohol industry and the social ambivalence to drinking. More recently, the need to have interventions for harmful and hazardous use, the need to develop evidence based combinations of pharmacotherapy and psychosocial interventions and stepped care solutions have been highlighted. [173] Standard treatment guidelines for alcohol and other drug use disorders have suggested specific measures at the primary, secondary and tertiary health care level, including at the solo physician level. [174] An earlier report in 1988 on training general practitioners on management of alcohol related problems [175] suggests that their involvement in alcohol and health education was modest, involvement in control and regulatory activities minimal, and they perceived no role in the development of a health and alcohol policy.

There have been reviews of the National Master Plan 1994, which envisaged different responsibilities for the Ministries of Health and the Ministry of Welfare (presently Social Justice and Empowerment) and the Drug Dependence Program 1996. [176],[177] A proposal for adoption of a specialty section on addiction medicine [178] includes the development of a dedicated webpage, co-ordinated CMEs, commissioning of position papers, promoting demand reduction strategies and developing a national registry.

 Summary and Conclusions

While epidemiological research has now provided us with figures for national-level prevalence, it would be prudent to recognize that there are regional differences in substance use prevalence and patterns. It is also prudent to recognize the dynamic nature of substance use. There is thus a need for periodic national surveys to determine changing prevalence and incidence of substance use. Substance use is associated with significant mortality and morbidity. Substance use among women and children is increasingly becoming the focus of attention and merits further research. Pharmaceutical drug abuse and inhalant use are serious concerns. For illicit drug use, rapid assessment surveys have provided insights into patterns and required responses. Drug related emergencies have not been adequately studied in the Indian context.

Biological research has focused on two broad areas, neurobiology of vulnerability and a few studies on molecular genetics. There is a great need for translation research based on the wider body of basic and animal research in the area.

Clinical research has primarily focused on alcohol. An area which has received relatively more attention in substance related comorbidity. There is very little research on development and adaptation of standardized tools for assessment and monitoring, and a few family studies. Ironically, though several evidence based treatments have now become available in the country, there are very few studies examining the utilization and effectiveness of these treatments, given that most treatment is presently unsubsidized and dependent on out of pocket expenditure. Both pharmacological and psychosocial interventions have disappointingly attracted little research. Course and outcome studies emphasize the need for better follow-up in this group.

While a considerable number of publications have lamented the lack of a coherent policy, the need for human resource enhancement and professional training and recommended a stepped-care multipronged approach, much remains to be done on the ground.

Finally, publication interest in the Indian Journal of Psychiatry in the area of substance use will undoubtedly increase, with the journal having become indexed.


1Gopinath PS. Epidemiology of mental illness in Indian village. Prevalence survey for mental illness and mental deficiency in Sakalawara (MD thesis), 1968.
2Elnagar MN, Maitra P, Rao MN. Mental health in an Indian rural community. Br J Psychiatry 1971;118:499-503.
3Dube KC, Handa SK. Drug use in health and mental illness in an Indian population. Br J Psychiatry 1971;118:345-6.
4Varghese A, Beig A, Senseman LA, Rao SS, Benjamin. A social and psychiatric study of a representative group of families in Vellore town. Indian J Med Res 1973;61:608-20.
5Thacore VR. Drug-abuse in India with special reference to Lucknow. Indian J Psychiatry 1972;14:257-61.
6D.N Nandi, S Ajmany, H Ganguli, G Benerjee, G.C Boral, A Ghosh, S Sarkar, et al. Psychiatric disorders in a rural community in West Bengal An epidemiological study. Indian J Psychiatry 1975;17:87-99.
7Lal B, Singh G. Drug abuse in Punjab. Br J Addict 1979;74:441-27.
8Sethi BB, Trivedi JK. Drug abuse in rural population. Indian J Psychiatry 1979;21:211-6.
9Varma VK, Singh A, Singh S, Malhotra AK. Extent and pattern of alcohol use in North India. Indian J Psychiatry 1980;22:331-7.
10Ponnudorai R, Jayakar J, Raju B, Pattamuthu R. An epidemiological study of alcoholism. Indian J Psychiatry 1991;33:176-9.
11Premranjan KC, Danabalan M, Chandrasekhar R, Srinivasa DK. Prevalence of psychiatric morbidity in an urban community of Pondicherry. Indian J Psychiatry 1993;35:99-102.
12Jena R, Shukla TR, Pal H. Drug abuse in a rural community in Bihar: Some psychosocial correlates. Indian J Psychiatry 1996;38:43-6.
13Ghulam R, Rahman I, Naqi S, Gupta SR. An epidemiological study of drug abuse in urban population of Madhya Pradesh. Indian J Psychiatry 1996;38:160-5.
14Singh RB, Ghosh S, Niaz MA, Rastogi V, Wander GS. Validation of tobacco and alcohol intake questionnaire in relation to food intakes for the five city study and proposed classification for indians. J Physicians India 1998;46:587-91.
15Hazarika NC, Biswas D, Phukan RK, Hazarika D, Mahanta J. Prevalence and pattern of substance abuse at bandardewa, a border area of Assam and Arunachal Pradesh. Indian J Psychiatry 2000;42:262-6.
16Sharma S, Singh MM. Prevalence of mental disorders: An epidemiological study In Goa. Indian J Psychiatry 2001;43:118-26.
17Mohan D, Chopra A, Sethi H. Incidence estimates of substance use disorders in a cohort from Delhi, India. Indian J Med Res 2002;115:128-35.
18Meena, Khanna P, Vohra AK, Rajput R. Prevalence and pattern of alcohol and substance abuse in urban areas of Rohtak city. Indian J Psychiatry 2002;44:348-52.
19Chagas Silva M, Gaunekar G, Patel V, Kukalekar DS, Fernandes J. The prevalence and correlates of hazardous drinking in industrial workers: A community study from Goa India. Alcohol Alcohol 2003;38:79-83.
20Gupta PC, Saxena S, Pednekar M. Alcohol consumption among middle-aged and elderly men: A community study from Western India. Alcohol Alcohol 2003;38:327-31.
21Benegal V, Gururaj G, Murthy P. Report on a WHO Collaborative Project on Unrecorded Consumption of Alcohol in Karnataka, India. Bangalore, India: National Institute of Mental Health and Neurosciences 2003.
22Chaturvedi HK, Phukan RK, Mahanta J. Sociocultural diversity and substance use pattern in Arunachal Pradesh, India. Drug Alcohol Depend 2004;74:97-104.
23Gururaj G, Isaac MK, Girish N, Subbukrishna DK. Final report of the pilot study establishing health behaviour surveillance in respect of mental health. Report submitted to Ministry of Health and Family Welfare, Government of India and WHO India Country Office, New Delhi: 2004.
24Gururaj G, Girish N, Benegal V, Chandra V, Pandav R. Burden and Socioeconomic impact of alcohol, The Bangalore Study, World Health Organization, South East Asia Regional office, New Delhi: 2006.
25Chavan B, Arun P, Bhargava R, Singh GP. Prevalence of alcohol and drug dependence in rural and slum population of Chandigarh: A community survey. Indian J Psychiatry 2007;49:44-8.
26Reddy MV, Chandrashekhar CR. Prevalence of mental and behavioural disorders in India: A meta-analysis. Indian J Psychiatry 1998;40:149-57.
27John A, Barman A, Bal D, Chandy G, Samuel J, Thokchom M, et0 al. Hazardous alcohol use in rural southern India: Nature, prevalence and risk factors. Natl Med J India 2009;22:123-5.
28Sampath SK, Chand PK, Murthy P. Problem drinking among male inpatients in a rural general hospital. Indian J Community Med 2007;32:93.
29Ray R. The Extent, Pattern and Trends Of Drug Abuse In India, National Survey, Ministry Of Social Justice and Empowerment, Government Of India and United Nations Office On Drugs and Crime, Regional Office For South Asia, 2004.
30National Family Health Survey India-3. Available from: [Accessed on 2009 20 December]
31Kumar MS. Rapid Assessment Survey of Drug Abuse in India. United Nations Office on Drugs and Crime Regional Office for South Asia and Ministry of Social Justice and Empowerment, Government of India. New Delhi, India. Available from: [cited in 2002].
32United Nations Office on Drugs and Crime. Rapid Situation and Response Assessment of drugs and HIV in Bangladesh, Bhutan, India, Nepal and Srilanka: A regional report. Available from: th _june/RSRA%20Report%20(24-06-08).pdf. [Accessed on 2009 20 December]
33United Nations office on Drugs and Crime. World Drug Report 2009. Available at: [Accessed on 2009 20 December]
34Benegal V. India: Alcohol and public health. Addiction 2005;100:1051-6.
35Nayak RB, Murthy P. Fetal alcohol spectrum disorder. Indian Pediatr 2008;45:977-83.
36Murthy P, editor. Women and drug use in India. Substance, women and high risk assessment study: United Nations Office on Drugs and Crime, Ministry of Social Justice and Empowerment, Government of India and United Nations Development Fund for Women, 2008.
37Kumar MS, Sharma M. Women and substance use in India and Bangladesh. Subst Use Misuse 2008;43:1062-77.
38Ponnudurai R, Somasundaram O, Indira TP, Gunasekar P. Alcohol and drug abuse among internees. Indian J Psychiatry 1984;26:128-32.
39Seshadri S. Substance abuse among medical students and doctors: A call for action. Natl Med J India 2008;21:57-9.
40Bhan A. Substance abuse among medical professionals: A way of coping with job dissatisfaction and adverse work environments? Indian J Med Sci 2009;63:308-9.
41Sinha DN, Reddy KS, Rahman K, Warren CW, Jones NR, Asma S. Linking Global Youth Tobacco Survey (GYTS) data to the WHO framework convention on tobacco control: The case for India. Indian J Public Health 2006;50:76-89.
42Dhawan A, Jain R, Kumar N. Proceedings of the workshop on "Assessment of Role of Tobacco as a Gateway Substance and Information available on Evidence relating to tobacco, alcohol and other forms of substance abuse. All India Institute of Medical Sciences and World Health Organization, New Delhi: 2004.
43Bansal RK, Banerjee S. Substance use by child labourers. Indian J Psychiatry 1993;35:159-61.
44Tripathi BM, Lal R. Substance abuse in children and adolescents. Indian J Pediatrics 1999;66:569-75.
45Praharaj, Kumar S, Verma P, Arora M. Inhalant abuse (typewriter correction fluid) in street children. J Addict Med 2008;2:175-7.
46Benegal V, Sathyaprakash M, Nagaraja D. Alcohol misuse in the Andaman and Nicobar Islands. Report on project commissioned by the Indian Council of Medical Research and funded by Action Aid, India: 2008.
47Gupta R, Narang RL, Gupta KR, Singh S. Drug abuse among rickshaw pullers in industrial town of Ludhiana. Indian J Psychiatry 1986;28:145-9.
48Dutta S, Kar N, Thirthalli J, Nair S. Prevalence and risk factors of psychiatric disorders in an industrial population in India. Indian J Psychiatry 2007;49:103-8.
49Satija DC, Khatri JS, Satija YK, Nathawat SS. A study of prevalence and patterns of drug abuse in industrial workers. Int J Soc Psychiatry 1997;13:47-52.
50Selvaraj V, Prasad S, Ashok MV, Appayya MP. Women alcoholics: Are they different from men alcoholics? Indian J Psychiatry 1997;39:288-93.
51Abraham J, Chandrasekaran R, Chitralekha V. A prospective study of treatment outcome in alcohol dependence from a deaddiction centre in India. Indian J Psychiatry 1997;39:18-23.
52Babu RS, Sengupta SN. A study of problem drinkers in a general hospital. Indian J Psychiatry 1997;39:13-7.
53Vohra AK, Yadav BS, Khurana H. A study of psychiatric comorbidity in alcohol dependence. Indian J Psychiatry 2003;45:247-50.
54Gupta AK, Jha BK, Devi S. Heroin addiction: Experiences from general psychiatry out patients department. Indian J Psychiatry 1987;29:81-3.
55Sharma AK, Sahai M. Pattern of drug use in Indian heroin addicts. Indian J Psychiatry 1990;32:341-4.
56Samantary PK, Ray R, Chandiramani K. Predictors of inpatient treatment completion of subjects with heroin dependence. Indian J Psychiatry 1997;39:282-7.
57Saluja BS, Grover S, Irpati AS, Mattoo SK, Basu D. Drug dependence in adolescents 1978-2003: A clinical-based observation from North India. Indian J Pedatr 2007;74:455-8.
58Grover S, Irpati AS, Saluja BS, Mattoo SK, Basu D. Substance-dependent women attending a de-addiction center in North India: Socio-demographic and clinical profile. Indian J Med Sci 2005;59:283-91.
59Narang RL, Gupta R, Mishra BP, Mahajan R. Temperamental characteristics and psychopathology among children of alcoholics. Indian J Psychiatry 1997;39:226-31.
60Subodh BN, Murthy P, Chand PK, Arun K, Bala SN, Benegal V, Madhusudhan S. A case of poppy tea dependence in an octogenarian lady. Drug Alcohol Rev 2010; 29 (2):216-218.
61Gururaj G. Alcohol and road traffic injuries in South Asia: Challenges for prevention. J Coll Physicians Surg Pak 2004;14:713-8.
62Benegal V, Gururaj G, Murthy P. Project Report on a WHO multicentre collaborative project on establishing and monitoring alcohol's involvement in casualties: 2000-2001. Available from: [last cited in 2002].
63Bhalla A, Dutta S, Chakrabarti A. A profile of substance abusers using the emergency services in a tertiary care hospital in Sikkim. Indian J Psychiatry 2006;48:243-7.
64Reddy KS, Gupta PC, editors. Report on Tobacco Control in India. Ministry of Health and Family Welfare, New Delhi: Government of India, 2004.
65Murthy P. Tilak Venkoba Rao Oration Alcohol dependence: Biological and clinical correlates. Indian J Psychiatry 2003;45:15-9.
66Subodh BN, Benegal V, Murthy P, Girish NR, Gururaj G. Alcohol related harm in India - an overview. Drug Abuse: News-n-Views 2008. p. 3-6.
67Grover S, Basu D. Cannabis and psychopathology: Update 2004. Indian J Psychiatry 2004;46:299-309.
68Solomon SS, Celentano DD, Srikrishnan AK, Vasudevan CK, Anand S, Kumar MS, et al. Mortality among injection drug users in Chennai, India (2005-2008). AIDS 2009;23:997-1004.
69Chandra PS, Carey MP, Carey KB, Prasada Rao PS, Jairam KR, Thomas T. HIV risk behaviour among psychiatric inpatients: Results from a hospital-wide screening study in southern India. Int J STD AIDS 2003;14:532-8.
70Panda S, Kumar MS, Lokabiraman S, Jayashree K, Satagopan MC, Solomon S, et al. Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. J Acquir Immune Defic SynDr. 2005;39:9-15.
71Srinivasan K, Augustine MK. A Study of alcohol related physical diseases in general hospital patients. Indian J Psychiatry 2000;42:247-52.
72Chowdhury AN, Sen P. Initiation of heroin abuse: The role of peers. Indian J Psychiatry 1992;34:34-5.
73Mattoo SK, Basu D, Malhotra A, Malhotra R. Relapse precipitants, life events and dysfunction in alcohol and opioid dependent men. Indian J Psychiatry 2003;45:39-44.
74Mattoo SK, Basu D. Clinical course of alcohol dependence. Indian J Psychiatry 1997;39:294-9.
75Manjunatha N, Sahoo S, Sinha BN, Khess CR, Isaac MK. Chronology of alcohol dependence: Implications in prevention. Indian J Community Med 2008;33:233-7.
76Dhawan A, Kumar R, Seema Y, Tripathi BM. The Enigma of craving. Indian J Psychiatry 2002;44:138-43.
77Saldanha D, Goel DS. Alcohol and the Soldier. Indian J Psychiatry 1992;34:351-8.
78Chaudhury S, Das SK, Ukil B. Psychological assessment of alcoholism in males. Indian J Psychiatry 2006;48:114-7.
79Saraswat N, Ranjan S, Ram D. Set-shifting and selective attentional impairment in alcoholism and its relation with drinking variables. Indian J Psychiatry 2006;48:47-51.
80SiriGowri DR, Suman LN, Rao SL, Murthy P. A study of executive functions in alcohol dependent individuals: Association of age, education and duration of drinking. Indian J Clin Psychology 2008;35:14-23.
81Sabhesan S, Natarajan M. Alcohol abuse and recovery after head Injury. Indian J Psychiatry 1987;29:143-8.
82Sabhesan S, Arumugham R, Natarajan M. Clinical indices of head injury and memory impairment. Indian J Psychiatry 1990;32:260-4.
83Agarwal AK, Sethi BB, Gupta SC. Physical and cognitive effects of chronic bhang (cannabis) intake. Indian J Psychiatry 1975;17:1-17.
84Sethi BB, Trivedi JK, Singh H. Long term effects of cannabis. Indian J Psychiatry 1981;23:224-9.
85Rao AV, Chinnian RR, Pradeep D, Rajagopal P. Cannabis (Ganja) and cognition. Indian J Psychiatry 1975;17:233-7.
86A Venkoba Rao, C Ramachandran, S Parvathi Devi, N Hariharasubramanian, R Rawlin Chinnian, D Pradeep, P Rajagopal, et al. Ganja and muscle. Indian J Psychiatry 1975;17:223-32.
87Kumar R, Dhawan A. Reasons for transition and reverse transition in patients of heroin dependence. Indian J Psychiatry 2002;44:19-23.
88Basu D, Nitin G, Narendra S, Mattoo SK, Parmanand K. Endorsement and concordance of ICD-10 versus DSM-IV criteria for substance dependence: Indian perspective. Indian J Psychiatry 2000;42:378-86.
89Ray R, Neeliyara T. Alcoholism-diagnostic criteria and variability. Indian J Psychiatry 1989;31:247-9.
90Ray R, Chandrasekhar K. Detection of alcoholism among psychiatric inpatients. Indian J Psychiatry 1982;24:389-93.
91Manikant S, Tripathi BM, Chavan BS. Utility Of CIWA - a in alcohol withdrawal assessment. Indian J Psychiatry 1992;34:347-50.
92Chaudhury S, Das SK, Mishra BS, Ukil B, Bhardwaj P, Dinker NL. Physiological assessment of male alcoholism. Indian J Psychiatry 2002;44:144-9.
93Ray R, Subash MN, Subbakrishna DK, Desai NG, SJ S, Ralte J. Male alcoholism-biochemical diagnosis and effect of abstinence. Indian J Psychiatry 1988;30:339-43.
94Mathrubootham N, Hariharan G, Ramakrishnan AN, Muthukrishanan V. Comparison of questionnaires and laboratory tests in the detection of excessive drinkers and alcoholics. Indian J Psychiatry 1999;41:42-8.
95Shankar SK, Ray R, Desai NG, Gentiana M, Shetty KT, Subbakrishna DK. Alcoholic liver disease in a psychiatric hospital. Indian J Psychiatry 1986;28:35-9.
96Mattoo SK, Basu D, Malhotra A, Malhotra R. Motivation for addiction treatment-Hindi scale: Development and factor structure. Indian J Psychiatry 2002;44:131-7.
97Neeliyara T, Nagalakshmi SV. Development of motivation scale - clinical validation with alcohol dependents. Indian J Psychiatry 1994;36:79-84.
98Janakiramaiah N, Venkatesha PJ, Raghu TM, Subbakrishna DK, Gangadhar BN, Murthy P. Brief addiction rating scale (Bars) for alchoholics: Description and reliabilty. Indian J Psychiatry 1999;41:222-7.
99Devadasan K. The effect of smoking on certain clinical diagnostic tests. Indian J Psychiatry 1976;18:151-6.
100Varma S, Sengupta S. Type A- Type B clustering of alcoholics - A preliminary report from an Indian Hopsital. Indian J Psychiatry 2000;42:363-9.
101De B, Surendra K, Basu D. Age at onset typology in opioid dependent men: An exploratory study. Indian J Psychiatry 2002;44:150-60.
102Gupta N, Basu D. The ongoing quest for sub-typing substance abuse: Current status. Indian J Psychiatry 1999;41:289-99.
103Jhingan HP, Jain R, Desai NG, Vaswani M, Tripathi BM, Pandey RM. Validity of self-report of recent opiate use in treatment setting. Indian J Med Sci 2002;56:495-500.
104Sarkar J, Murthy P, Singh SP. Psychiatric co-morbidity of cannabis abuse. Indian J Psychiatry 2003;45:182-8.
105Goel D, Netto D. Cannabis: The habit and psychosis. Indian J Psychiatry 1975;17:238-43.
106Kulhalli V, Isaac M, Murthy P. Cannabis-related psychosis: Presentation and effect of abstinence. Indian J Psychiatry 2007;49:256-61.
107Kisore P, Lal N, Trivedi JK, Dalal PK, Aga VM. A study of comorbidity in psychoactive substance dependence patients. Indian J Psychiatry 1994;36:133-7.
108Singh NH, Sharma SG, Pasweth AM. Psychiatric co-morbidity among alcohol dependants. Indian J Psychiatry 2005;47:222-4.
109Basu D, Raj L, Mattoo SK, Malhotra A, Varma VK. The agoraphobic alcoholic: Report of two cases. Indian J Psychiatry 1993;35:185-6.
110Khalid A, Kunwar AR, Rajbhandari KC, Sharma VD, Regmi SK. A study of prevalence and comorbidity of depression in alcohol dependence. Indian J Psychiatry 2000;42:434-8.
111Sringeri SK, Rajkumar RP, Muralidharan K, Chandrashekar CR, Benegal V. The association between attention-deficit/hyperactivity disorder and early-onset alcohol dependence: A retrospective study. Indian J Psychiatry 2008;50:262-5.
112Murthy P, Taly AB, Jayakumar S. Seizures in alcohol dependence. German J Psychiatry 2007;10:54-7.
113Parkar SR, Seethalakshmi R, Adarkar S, Kharawala S. Is this 'complicated' opioid withdrawal? Indian J Psychiatry 2006;48:121-2.
114Mattoo SK, Singh SM, Bhardwaj R, Kumar S, Basu D, Kulhara P. Prevalence and correlates of epileptic seizure in substance-abusing subjects. Psychiatry Clin Neurosci 2009;63:580-2.
115Srinivasan TN, Suresh TR, Devar JV, Jayaram V. Alcoholism and psoriasis-an immunological relationship. Indian J Psychiatry 1991;33:302-4.
116Arackal BS, Benegal V. Prevalence of sexual dysfunction in male subjects with alcohol dependence. Indian J Psychiatry 2007;49:109-12.
117Sampath G, Kumar YV, Channabasavanna SM, Keshavan MS. Alcoholic hallucinosis and paranoid schizophrenia-A comparative (clinical and follow up) study. Indian J Psychiatry 1980;22:338-42.
118Satija DC, Sharma DK, Gaur A, Nathawat SS. Prognostic significance of psychopathology in the abstinence from opiate addiction. Indian J Psychiatry 1989;31:157-62.
119Pal H, Rajesh K, Shashi B, Neeraj B. Psychiatric co-morbidity associated with pheniramine abuse and dependence. Indian J Psychiatry 2005;47:60-2.
120Goswami S, Singh G, Mattoo SK, Basu D. Courses of substance use and schizophrenia in the dual-diagnosis patients: Is there a relationship? Indian J Med Sci 2003;57:338-46.
121Aich TK, Sinha VK, Khess CR, Singh S. Demographic and clinical correlates of substance abuse comorbidity in schizophrenia 2004;46:135-9.
122Aich TK, Sinha VK, Khess CR, Singh S. Substance abuse co-morbidity in schizophrenia: An inpatient study of course and outcome. Indian J Psychiatry 2005;47:33-8.
123Thirthalli J, Venkatesh BK, Gangadhar BN. Psychoses and illicit drug use: Need for cross-cultural studies. Acta Psychiatr Scand 2008;118:86.
124Isaac M, Chand P, Murthy P. Schizophrenia outcome measures in the wider international community. Br J Psychiatry Suppl 2007;191:s71-7.
125Basu D, Gupta N. Management of dual diagnosis patients: Consensus, controversies and considerations. Indian J Psychiatry 2000;42:34-47.
126Bhowmick P, Tripathi BM, Jhingan HP, Pandey RM. Social support, coping resources and codependence in spouses of individuals with alcohol and drug dependence. Indian J Psychiatry 2001;43:219-24.
127Rao TSS, Kuruvilla K. A study on the coping behaviours of wives of alcoholics. Indian J Psychiatry 1992;34:359-65.
128Rao TSS, Kuruvilla K. A Study on the personality characteristics of wives of alcoholics. Indian J Psychiatry 1991;33:180-6.
129Ponnudurai R, Uma TS, Rajarathinam S, Krishnan VS. Determinants of sucidial attempts of wives of substance abusers. Indian J Psychiatry 2001;43:230-4.
130Andrade C, Sarmah PL, Channabasavanna SM. Psychological well-being and morbidity in parents of narcotic-dependent males. Indian J Psychiatry 1989;31:122-7.
131Gupta S, Kulhara P. Cellular and molecular mechanisms of drug dependence: An overview and update. Indian J Psychiatry 2007;49:85-90.
132Muthy P, Guru SC, Channabasavanna SM, Subbakrishna DK, Shetty KT. Erythocyte aldehyde dehydrogenase - a potential marker for alcohol dependence. Indian J Psychiatry 1996;38:38-42.
133Bhaskar LV, Thangaraj K, Osier M, Reddy AG, Rao AP, Singh L, et al. Single nucleotide polymorphisms of the ALDH2 gene in six Indian populations. Ann Hum Biol 2007;34:607-19.
134Vaswani M, Prasad P, Kapur S. Association of ADH1B and ALDH2 gene polymorphisms with alcohol dependence: A pilot study from India. Hum Genomics 2009;3:213-20.
135Deb I, Chakraborty J, Gangopadhyay PK, Choudhury SR, Das S. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction. J Neurochem 2009. [Epub ahead of print]
136Sringeri SK, Rajkumar RP, Muralidharan K, Chandrashekar CR, Benegal V. The association between attention-deficit/hyperactivity disorder and early-onset alcohol dependence: A retrospective study. Indian J Psychiatry 2008;50:262-5.
137Benegal V, Venkatasubramanian GV, Antony G, Jaykumar PN. Differences in brain morphology between subjects at high and low risk for alcoholism. Addict Biol 2006;12:122-32.
138Venkatasubramanian G, Anthony G, Reddy US, Reddy VV, Jayakumar PN, Benegal V. Corpus callosum abnormalities associated with greater externalizing behaviors in subjects at high risk for alcohol dependence. Psychiatry Res 2007;156:209-15.
139Muralidharan K, Venkatasubramanian G, Pal P, Benegal V. Transcallosal conduction abnormalities in alcohol-naοve male offspring of alcoholics. Addict Med Addict Biol 2008;13:373-9.
140Silva MC, Benegal V, Devi M, Mukundan CR. Cognitive deficits in children of alcoholics: At risk before the first sip! Indian J Psychiatry 2007;49:182-8.
141Benegal V, Nayak M., Murthy P, Chandra, P, Gururaj G. Women and alcohol in India. In Alcohol, Gender and Drinking Problems: Perspectives from Low and Middle Income Countries. Obot IS. Room R, editor. Geneva: World Health Organisation, 2005.
142Singh SM, Basu D. The P300 event-related potential and its possible role as an endophenotype for studying substance use disorders: A review. Addict Biol 2009;14:298-309.
143Jagadeesh AN, Prabhu VR, Chaturvedi S K, Mukundan CR, Benegal V. Differential EEG response to ethanol across subtypes of alcoholics. Mol Psychiatry 1999;4:S45.
144Grover S, Bhateja G, Basu D. Pharmacoprophylaxis of alcohol dependence: Review and update part I: Pharmacology. Indian J Psychiatry 2007;49:19-25.
145Grover S, Basu D, Bhateja G. Pharmacoprophylaxis of alcohol dependence: Review and update part II: Efficacy. Indian J Psychiatry 2007;49:26-32.
146Murali T, Rao IV, Keshavan MS, Narayanan HS. Thiamine refractory- wernicke-korsakoffs syndrome-a case report. Indian J Psychiatry 1983;25:80-1.
147Mohan KS, Pradhan N, Channabasavanna SM. A report of subclinical psychological deterioration (A type of alcoholic dementia). Indian J Psychiatry 1983;25:243-5.
148Kumar CN, Andrade C, Murthy P. A randomized, double-blind comparison of lorazepam and chlordiazepoxide in patients with uncomplicated alcohol withdrawal. J Stud Alcohol Drugs 2009;70:467-74.
149Chand PK, Murthy P. Megadose lorazepam dependence. Addiction 2003;98:1635-6.
150De Sousa AA, De Sousa J, Kapoor H. An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence. J Subst Abuse Treat 2008;34:460-3.
151Sousa AD, Sousa AD. A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol Alcohol 2004;39:528-31.
152Sousa AD, Sousa AD. An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 2005;40:545-8.
153Basu D, Jhirwal OP, Mattoo SK. Clinical characterization of use of acamprosate and naltrexone: Data from an addiction center in India. Am J Addict 2005;14:381-95.
154Galgali RB, Srinivasan K, Souza GD. Study of spirometry and airway reactivity in patients on disulfiram for treatment of alcoholism. Indian J Psychiatry 2002;44:273.
155Gangadhar BN, Subramanya H, Venkatesh H, Channabasavanna SM. Clonidine in Opiate detoxification. Indian J Psychiatry 1982;24:387-8.
156Subramanya, Channabasavanna SM. Clonidine in opiate withdrawal. Indian J Psychiatry 1981;23:375-6.
157Satija DC, Natani GD, Purohit DR, Gaur R, Bhati GS. A double blind compartive study of usefulness of clonidine and symptomatic therapy in opiate detoxification. Indian J Psychiatry 1988;30:55-9.
158Nigam AK, Ray R, Tripathi BM. Non completers of opiate detoxification programme. Indian J Psychiatry 1992;34:376-9.
159Rao RV, Dhawan A, Sapra N. Opioid maintenance therapy with slow release oral morphine: Experience from India. J Substance Use 2005;10:259-61.
160Muralidharan K, Rajkumar RP, Mulla U, Nayak RB, Benegal V. Baclofen in the management of inhalant withdrawal: A case series. Prim Care Companion J Clin Psychiatry 2008;10:48-51.
161Chandiramani K, Tripathi BM. Psycho - educational group therapy for alcohol and drug dependence recovery. Indian J Psychiatry 1993;35:169-72.
162Kumar PS, Thomas B. Family intervention therapy in alcohol dependence syndrome: One-year follow-up study. Indian J Psychiatry 2007;49:200-4.
163Murthy P, editor. Principal author and Scientific Editor. Partnerships for Drug Demand Reduction in India. Ministry of Social Justice and Empowerment, Govt of India, United Nations Drug Control Program, International Labour Organization, European Commission publication; 2002.
164Chandrasekaran R, Sivaprakash B, Chitraleka V. Five years of alcohol de-addiction services in a tertiary care general hospital. Indian J Psychiatry 2001;43:58-60.
165Prasad S, Murthy P, Subbakrishna DK, Gopinath PS. Treatment setting and follow up in alcohol dependence. Indian J Psychiatry 2000;42:387-92.
166Murthy P, Chand P, Harish MG, Thennarasu K, Prathima S, Karappuchamy, et al. Outcome of alcohol dependence: The role of continued care. Indian J Community Med 2009;34:148-51.
167Kar N, Sengupta S, Sharma P, Rao G. Predictors of outcome following alcohol deaddiction treatment: Prospective longitudinal study for one year. Indian J Psychiatry 2003;45:174-7.
168Ranganathan S. Conversation with Shanthi Ranganathan. Addiction 2005;100:1578-83.
169Varma VK, Singh A, Malhotra AK, Das K, Singh S. Popular attitudes towards alcohol, use and alcoholism. Indian J Psychiatry 1981;23:343-50.
170Mohan D, Adityanjee, Saxena S, Sethi HS. Drug and alcohol dependence: The past decade and future, view from a development country. Indian J Psychiatry 1983;25:269-74.
171Mahal A. What works in alcohol policy? Evidence from rural India, Economic and Political weekly. 2000.
172Ramachandran V. The prevention of alcohol related problems. Indian J Psychiatry 1991;33:3-10.
173Benegal V, Chand PK, Obot IS. Packages of care for alcohol use disorders in low- and middle-income countries. PLoS Med 2009;6:e1000170.
174Armed Forces Medical College. Standard treatment guidelines and costing. Available from: 26 Nov 2007.
175Varma VK, Malhotra AK. Management of alcohol related problems in general practice in north India. Indian J Psychiatry 1988;30:211-9.
176Malhotra A, Mohan A. National policies to meet the challenge of substance abuse: Programmes and implementation. Indian J Psychiatry 2000;42:370-7.
177Ray R. Substance Abuse and the growth of de-addiction centres: The challenge of our times. In: Agarwal SP, editor. Mental Health: An Indian Perspective 1946-2003. Directorate General of Health Services, Ministry of Health and Family Welfare, New Delhi: 2003.
178Benegal V, Bajpai A, Basu D, Bohra N, Chatterji S, Galgali RB, et al. Proposal to the Indian Psychiatric Society for adopting a specialty section on addiction medicine (alcohol and other substance abuse). Indian J Psychiatry 2007;49:277-82.